Your Cancer Team

Cancer Center of Southern California Physicians

Dr. Chawla is the Director of the Cancer Center of Southern California, a treatment and clinical research facility specializing in advanced cancer therapies. Dr. Chawla and his staff are internationally recognized for their innovative work and ability to help patients for whom standard treatments have proven ineffective. The Center has conducted innovative and ground-breaking clinical research in targeted gene therapy, intra-arterial chemotherapy, the role of oncogenes, the role of monoclonal antibodies in diagnosis and treatment and antiemetics.

Also on staff at the Center is Dr. Doris Quon, who received her M.D./PhD from UCLA, where she also completed her residency, and is board certified in oncology, hematology and internal medicine.
The physicians and staff at the Cancer Center have helped numerous patients with innovative, life-saving cancer treatments and combine commitment, passion and dedication in their efforts. The doctors are frequent presenters at international conferences, including ASCO (American Society of Clinical Oncology), and they have published or contributed to articles on cancer treatment for more than 100 research publications in leading national and international peer-reviewed journals.


Sant P. Chawla M.D., FRACP

Sant ChawlaSant P. Chawla, M.D., is director of the Cancer Center of Southern California in Santa Monica, California, a comprehensive cancer treatment and clinical research facility. Dr. Chawla is medically licensed in Texas and California, and his medical board certification is in Medical Oncology and Internal Medicine. In additional to his director’s role at the Cancer Center, Dr. Chawla is a medical oncologist at Cedars-Sinai Comprehensive Cancer Center and an adjunct associate professor at Stanford University and the University of Texas, M.D. Anderson Cancer Center. He holds clinical faculty positions at prestigious cancer centers, including USC, UCLA, and the John Wayne Cancer Institute at St. John’s Hospital, Santa Monica, California.

Dr. Chawla combines patient care with his groundbreaking research in pancreatic carcinoma, gynecologic tumors, breast cancer, glioblastoma, malignant peripheral nerve sheath tumors, lung cancer and gastrointestinal tumors. He is internationally recognized as a pioneering physician who’s received numerous accolades and recognition for his work in sarcoma and is internationally recognized as a leading authority in treatment and clinical research in sarcoma therapy and bone and soft-tissue sarcomas. Dr. Chawla’s work can be credited as the foundation of numerous other breakthroughs in cancer treatment.

Dr. Chawla’s achievements in clinical research started in the 1980s with his pioneering work for young sarcoma patients. His research led to the development of a limb-saving treatment for osteosarcoma replacing amputation as the primary treatment. In the years since, Dr. Chawla has led over 60 clinical trials for cancer drugs with many of them approved by the EMA and FDA. In fact, the center recently completed a breakthrough Phase II trial for Aldoxorubicin (second line for soft tissue sarcomas) which reported an increase in progression-free and overall survival rates without any observed cardiotoxicity.

The doctor’s medical education began in his home country of India where he received his medical degree and served his residency in Internal Medicine at the All India Institute of Medical Sciences in New Delhi. Dr. Chawla continued his education in New Zealand at the Auckland Hospital in Auckland, for his specialization in medical oncology. Next, he completed his fellowship in medical oncology at New Zealand’s Fellow Royal Australasian College of Physicians (F.R.A.C.P.). Recognizing his outstanding academic accomplishments, the prestigious M.D. Anderson Cancer Center of the University of Texas invited him to continue his fellowship in oncology. M.D. Anderson is internationally recognized for excellence in cancer patient care, research, education, and prevention. M.D. Anderson’s reputation as the top-ranked cancer hospital in the United States is based on its numerous and extraordinary research-based contributions benefiting people everywhere. M.D. Anderson is recognized as the leader in innovative cancer therapy, and it is here that Dr. Chawla learned and enhanced his own understanding of the disease, preparing him for a pioneering career in sarcoma treatment and research.

Doris V. Quon, MD, PhD

Doris QuonDoris V. Quon, MD, PhD received her board certification in Oncology, Internal Medicine, and Hematology. She is Associate Medical Director at the Cancer Center of Southern California, and manages the coordination of the center’s federally funded (Region IX) Hemophilia activities. Dr. Quon is also the current Medical Director of the Hemophilia Foundation of Southern California. She was appointed Associate Director then Co-Director of the Hemophilia Treatment Center at Orthopaedic Hospital where she began her medical training in 2000. She has an M.D. and Ph.D. from the UCLA School of Medicine and completed an Internal Medicine residency then Fellowship in Hematology-Oncology at Medical Center at UCLA. Dr. Quon’s professional and academic achievements have been recognized by her receipt of numerous honors and awards including the ASCO Young Investigator Award, AOA Medical Student Research Award, and Alumni Association Graduate Student Distinguish Scholar Award.


Contact the Cancer Center Specialists Today

Cancer Center of Southern California specialists are dedicated to providing their patients with a treatment solution for the best outcome possible. If you have been diagnosed with cancer recently or seek another opinion about your cancer treatment, please contact us at 310-552-9999 to schedule a consultation for a private conversation.

Learn more about treatment methodology at the Cancer Center.